Fairest of them all for myelodysplastic syndromes

被引：2

作者：

Estey, Elihu H. ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

来源：

BLOOD | 2008年 / 111卷 / 01期

关键词：

D O I：

10.1182/blood-2007-10-115980

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Several therapeutic options are now available for patients with low-risk myelodysplastic syndrome (MDS).

引用

页码：6 / 6

页数：1

共 4 条

[1] A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin plus granulocyte colony-stimulating factor:: significant effects on quality of life [J].

Hellström-Lindberg, E ;

Gulbrandsen, N ;

Lindberg, G ;

Ahlgren, T ;

Dahl, IMS ;

Dybedal, I ;

Grimfors, G ;

Hesse-Sundin, E ;

Hjorth, M ;

Kanter-Lewensohn, L ;

Linder, O ;

Luthman, M ;

Löfvenberg, E ;

Öberg, G ;

Porwit-MacDonald, A ;

Rådlund, A ;

Samuelsson, J ;

Tangen, JM ;

Winquist, I ;

Wisloff, F .

BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (06) :1037-1046

[2] Decitabine improves patient outcomes in myelodysplastic syndromes - Resuits of a Phase III randomized study [J].

Kantarjian, H ;

Issa, JPJ ;

Rosenfeld, CS ;

Bennett, JM ;

Albitar, M ;

DiPersio, J ;

Klimek, V ;

Slack, J ;

de Castro, C ;

Ravandi, F ;

Helmer, R ;

Shen, LL ;

Nimer, SD ;

Leavitt, R ;

Raza, A ;

Saba, H .

CANCER, 2006, 106 (08) :1794-1803

[3] Low IPSS score and bone marrow hypocellularity in MDS patients predict hematological responses to antithymocyte globulin [J].

Lim, Z. Y. ;

Killick, S. ;

Germing, U. ;

Cavenagh, J. ;

Culligan, D. ;

Bacigalupo, A. ;

Marsh, J. ;

Mufti, G. J. .

LEUKEMIA, 2007, 21 (07) :1436-1441

[4] Further analysis of trials with azacitidine in patients with myelodysplastic syndrome: Studies 8421, 8921, and 9221 by the Cancer and Leukemia Group B [J].

Silverman, Lewis R. ;

McKenzie, David R. ;

Peterson, Bercedis L. ;

Holland, James F. ;

Backstrom, Jay T. ;

Beach, C. L. ;

Larson, Richard A. .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (24) :3895-3903

← 1 →